The expression of TNFRSF4 on tumor-infiltrating lymphocytes (TILs) has been studied in different tumor types, such as breast cancer, melanoma, B-cell lymphoma and head and neck cancers [35–40]. This evidence concerns the gene TNFRSF4 and melanoma.